Guardant Health and Quest Diagnostics will collaborate to offer Guardant’s Shield blood-based colorectal cancer test through Quest’s distribution network, the companies said Wednesday. Physicians will ...

Experts reviewed the use of targeted therapy in cholangiocarcinoma, along with efforts to reduce the burden of alcohol-associated liver disease in the general population, and to target steatotic liver ...